<DOC>
	<DOCNO>NCT01052441</DOCNO>
	<brief_summary>The purpose study evaluate diagnostic performance high iodine ( iopamidol 370 mg/dl ) content versus low iodine ( iodixanol 300 mg/dl ) content diagnostic accuracy contrast-enhanced Coronary Cardiac Computed Tomography ( CCTA ) use 64-detector-row CT scanner detection presence absence coronary artery obstruction compare invasive coronary angiography , standard truth .</brief_summary>
	<brief_title>Iodine Content Diagnostic AccuRacy Patient Comfort For Individuals Undergoing Cardiac Computed Tomography ( CT ) Scanning</brief_title>
	<detailed_description>Coronary Cardiac CT ( CCTA ) widely accept modality non-invasive evaluation coronary atherosclerosis . The diagnostic performance CCTA detect coronary artery plaque burden validate numerous study , reach negative predictive value 99 % . The current gold standard anatomic coronary image Invasive Coronary Angiography ( ICA ) portend small significant procedural-related complication 1.7 % . Non-invasive coronary image potential replace ICA variability diagnostic performance CCTA remain study . Among potential variable cause difference diagnostic performance perhaps degree opacification coronary artery iodinate contrast . While numerous contrast agent exist , provide improve low high contrast resolution ( delineate plaque arterial wall lumen plaque , respectively ) hypothetically , optimal agent . To date , however , well evaluate . Further , use contrast agent maximize patient comfort desire , may reduce heart rate increase heart rate variability , may turn improve diagnostic image quality CCTA . We hypothesize use low iodine content iso-osmolar agent - iodixanol - improve diagnostic performance patient comfort , compare high iodine content low osmolar iodinate contrast - iopamidol .</detailed_description>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>The subject ≥18 year old . The subject typical atypical chest pain suspect Coronary Artery Disease ( CAD ) refer elective coronary angiography . The subject must schedule undergo CATH procedure 72 hour 3 week CCTA procedure . The subject must undergo cardiac interventional treatment 2 procedure . The subject must sinus rhythm stable heart rate ≤75 beat per minute ( bpm ) heart rate &gt; 65 bpm , subject must agree use betablocker ( ) prior CT scan procedure achieve stable heart rate ≤65 bpm . The subject establish diagnosis CAD ) previous ICA , b ) prior myocardial infarction confirm electrocardiogram ( ECG ) , c ) prior revascularization ( balloon angioplasty , stent placement , coronary artery bypass grafting ( CABG ) . The subject know allergy iodinate contrast agent , include limited hive , anaphylactoid cardiovascular reaction , laryngeal edema bronchospasm . The subject impair renal function serum creatinine level 1.7 mg/dL ( 150 μmol/L ) . The subject atrial fibrillation/flutter irregular heart rhythm consider investigator interfere temporal acquisition cardiac CT image . The subject rest heart rate &gt; 100 bpm and/or rest systolic blood pressure &lt; 100 mm Hg . The subject artificial heart valve ( ) . The subject prior pacemaker internal defibrillator lead implantation . The subject 's rest heart rate &gt; 65 bpm betablocker therapy contraindicate . The subject contraindication Verapamil betablocker therapy administer . The subject contraindication nitroglycerin . The subject evidence ongoing active clinical instability .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>CCTA</keyword>
	<keyword>Coronary Artery Stenosis</keyword>
	<keyword>Iodinated Contrast</keyword>
	<keyword>Invasive Coronary Angiography</keyword>
</DOC>